Key Role of Ubc5 and Lysine-63 Polyubiquitination in Viral Activation of IRF3

Molecular Cell

Volumn 36, Issue 2, 2009, Pages 315-325

  Zeng, Wenwen ^a   Xu, Ming ^a   Liu, Siqi ^a   Sun, Lijun ^a   Chen, Zhijian J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

HUMDISEASE; MOLIMMUNO; PROTEINS

Indexed keywords

INTERFERON REGULATORY FACTOR 3; LYSINE DERIVATIVE; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; POLYUBIQUITIN; RETINOIC ACID INDUCIBLE PROTEIN I; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME 5; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL FREE SYSTEM; CELL STRAIN HEK293; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INNATE IMMUNITY; MITOCHONDRION; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RNA BINDING; RNA VIRUS; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS ACTIVATION;

AMINO ACID SEQUENCE; BIOCATALYSIS; CELL FRACTIONATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-3; LYSINE; MOLECULAR SEQUENCE DATA; POLYUBIQUITIN; PROTEIN STRUCTURE, TERTIARY; SENDAI VIRUS; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINATION; VIRUS ACTIVATION;

RNA VIRUSES;

EID: 70350004240     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2009.09.037     Document Type: Article

References (45)

1. Chau T.L., Gioia R., Gatot J.S., Patrascu F., Carpentier I., Chapelle J.P., O'Neill L., Beyaert R., Piette J., and Chariot A. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?. Trends Biochem. Sci. 33 (2008) 171-180
2. Cordier F., Grubisha O., Traincard F., Veron M., Delepierre M., and Agou F. The zinc finger of NEMO is a functional ubiquitin-binding domain. J. Biol. Chem. 284 (2008) 2902-2907
3. Cui S., Eisenacher K., Kirchhofer A., Brzozka K., Lammens A., Lammens K., Fujita T., Conzelmann K.K., Krug A., and Hopfner K.P. The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol. Cell 29 (2008) 169-179
4. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., and Chen Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103 (2000) 351-361
5. Ea C.K., Deng L., Xia Z.P., Pineda G., and Chen Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22 (2006) 245-257
6. Finley D., Ozkaynak E., and Varshavsky A. The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell 48 (1987) 1035-1046
7. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., and Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 (2003) 491-496
8. Friedman C.S., O'Donnell M.A., Legarda-Addison D., Ng A., Cardenas W.B., Yount J.S., Moran T.M., Basler C.F., Komuro A., Horvath C.M., et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9 (2008) 930-936
9. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., and Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446 (2007) 916-920
10. Gatot J.S., Gioia R., Chau T.L., Patrascu F., Warnier M., Close P., Chapelle J.P., Muraille E., Brown K., Siebenlist U., et al. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J. Biol. Chem. 282 (2007) 31131-31146
11. Guo B., and Cheng G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282 (2007) 11817-11826
12. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., Kamps M.P., Raz E., Wagner H., Hacker G., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 (2006) 204-207
13. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006) 994-997
14. Ishikawa H., and Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455 (2008) 674-678
15. Jin L., Waterman P.M., Jonscher K.R., Short C.M., Reisdorph N.A., and Cambier J.C. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28 (2008) 5014-5026
16. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., and Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005) 981-988
17. Kayagaki N., Phung Q., Chan S., Chaudhari R., Quan C., O'Rourke K.M., Eby M., Pietras E., Cheng G., Bazan J.F., et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 318 (2007) 1628-1632
18. Kim H.T., Kim K.P., Lledias F., Kisselev A.F., Scaglione K.M., Skowyra D., Gygi S.P., and Goldberg A.L. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 282 (2007) 17375-17386
19. Lin R., Heylbroeck C., Pitha P.M., and Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18 (1998) 2986-2996
20. McWhirter S.M., Tenoever B.R., and Maniatis T. Connecting mitochondria and innate immunity. Cell 122 (2005) 645-647
21. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
22. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., Perry A., and Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439 (2006) 208-211
23. Panne D., McWhirter S.M., Maniatis T., and Harrison S.C. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J. Biol. Chem. 282 (2007) 22816-22822
24. Paz S., Vilasco M., Arguello M., Sun Q., Lacoste J., Nguyen T.L., Zhao T., Shestakova E.A., Zaari S., Bibeau-Poirier A., et al. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29 (2009) 3401-3412
25. Pichlmair A., and Reis e Sousa C. Innate recognition of viruses. Immunity 27 (2007) 370-383
26. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., and Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 (2006) 997-1001
27. Ryzhakov G., and Randow F. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 26 (2007) 3180-3190
28. Saha S.K., Pietras E.M., He J.Q., Kang J.R., Liu S.Y., Oganesyan G., Shahangian A., Zarnegar B., Shiba T.L., Wang Y., and Cheng G. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25 (2006) 3257-3263
29. Sasai M., Shingai M., Funami K., Yoneyama M., Fujita T., Matsumoto M., and Seya T. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177 (2006) 8676-8683
30. Seth R.B., Sun L., Ea C.K., and Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (2005) 669-682
31. Seth R.B., Sun L., and Chen Z.J. Antiviral innate immunity pathways. Cell Res. 16 (2006) 141-147
32. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., and Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 300 (2003) 1148-1151
33. Stetson D.B., and Medzhitov R. Type I interferons in host defense. Immunity 25 (2006) 373-381
34. Stojdl D.F., Lichty B.D., tenOever B.R., Paterson J.M., Power A.T., Knowles S., Marius R., Reynard J., Poliquin L., Atkins H., et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4 (2003) 263-275
35. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
36. Wu C.J., Conze D.B., Li T., Srinivasula S.M., and Ashwell J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. Nat. Cell Biol. 8 (2006) 398-406
37. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., and Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19 (2005) 727-740
38. Xu M., Skaug B., Zeng W., and Chen Z.J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36 (2009) 302-314 this issue
39. Yoneyama M., and Fujita T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29 (2008) 178-181
40. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., and Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17 (1998) 1087-1095
41. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 730-737
42. You J., Cohen R.E., and Pickart C.M. Construct for high-level expression and low misincorporation of lysine for arginine during expression of pET-encoded eukaryotic proteins in Escherichia coli. Biotechniques 27 (1999) 950-954
43. Zhang M., Wu X., Lee A.J., Jin W., Chang M., Wright A., Imaizumi T., and Sun S.C. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J. Biol. Chem. 283 (2008) 18621-18626
44. Zhao T., Yang L., Sun Q., Arguello M., Ballard D.W., Hiscott J., and Lin R. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8 (2007) 592-600
45. Zhong B., Yang Y., Li S., Wang Y.Y., Li Y., Diao F., Lei C., He X., Zhang L., Tien P., and Shu H.B. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29 (2008) 538-550